Fairness for Fraudsters

By Richard Gallagher Fairness for Fraudsters The punishment for researchers guilty of misconduct is excessively punitive, and needs reform. At the end of the exclusion period, researchers should be able to participate again as full members of the scientific community. But they can't. The Office of Research Integrity (ORI), part of the US Public Health Service (PHS), serves an indispensible function: the identification and punishment

Written byRichard Gallagher
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The Office of Research Integrity (ORI), part of the US Public Health Service (PHS), serves an indispensible function: the identification and punishment of wrongdoers. A pioneer in the fight—and it is a fight—to retain honesty in scientific research, ORI continues to set standards for others around the world to follow. For the sake of research, researchers, and the wider community, it is essential that science's house is kept in order; we owe a debt of gratitude to ORI for the work that it does.

However, the system has a serious problem. Offenders are suffering far harsher penalties than intended.

As reported in a feature by Deputy Editor Alison McCook on page 28, a debarment from receiving federal funds for 3 years can effectively turn into a life sentence for researchers, permanently shutting down opportunities and eliminating career advancement, according to those who have experienced it first-hand. Many of those found ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies